Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Koi Research Labs LLC, operating under the brand Koi Peptides, is a United States-based supplier of high-purity research peptides and reference compounds intended strictly for laboratory and in-vitro research. Founded in 2022, the company provides a catalog of synthetic peptides, including GHK-Cu, BPC-157, TB-500, and KPV, as well as multi-peptide formulations like the Glow and Klow Peptide Stacks. Koi Research Labs emphasizes quality control and transparency, verifying every batch using reverse-phase HPLC for purity, mass spectrometry for identity, and LAL testing for endotoxins. Each product is shipped with a lot-specific Certificate of Analysis (COA) accessible via a public online library. The company operates fulfillment centers in both the United States and Canada to serve academic, institutional, and pharmaceutical researchers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Koi Research Labs.